Jaguar Health, Inc. (NASDAQ:JAGX) is one of the stocks that are grabbing investor focus today: sinking -4.63% or (-0.01 points) to $0.23 from its previous close of $0.24. Does this decline mean it the best stock to buy right now? The shares seem to have an active trading volume day with a reported 3520612 contracts so far this session. JAGX shares had a relatively better volume day versus average trading capacity of 6.58 million shares, but with a 38.86 million float and a -22.82% run over a week, it’s definitely worth keeping an eye on. The one year price forecast for JAGX stock indicates that the average analyst price target is $1.25 per share. This means the stock has a potential increase of 443.48% from where the JAGX share price has been trading recently which is between $0.23 and $0.254.
The shorts are running away from Jaguar Health, Inc. (JAGX) stock. The latest set of short interest data was released on 29 March 2019, and the numbers show a drop in short interest in JAGX shares. While short interest still represents only 1.82% of JAGX’s float, the number of shares shorted have fallen by -397729. The number of shares shorted fell to 309546 shares, down from 707275 shares during the preceding fortnight. With average daily trading volumes at 26815240 shares, days to cover decreased to about 1 days. The most recent news story about the stock that appeared in Yahoo Finance‘s news section was titled “Jaguar Health, Inc. Reports 2018 Fourth Quarter and Year End Financial Results” and dated April 10, 2019.
During the recent trading session for Jaguar Health, Inc. (NASDAQ:JAGX), the company witnessed their stock drop by $-0.07 over a week and tumble down $-0.23 from the price 20 days ago. When compared to their established 52-week high of $3.2, the high they recorded in their recent session happens to be lower. Their established 52-week high was attained by the company on 01/06/18. The recent low of $0.12 stood for a -92.73% since 12/24/18, a data which is good for most investors who are looking to take advantage of the stock’s recent rise. A beta of 1.25 is also allocated to the stock. Since the beta is greater than one, it implies that the stock is more volatile than the market, a data that traders are keeping close attention to.
Looking at the current readings for Jaguar Health, Inc., the two-week RSI stands at 43.04. This figure suggests that JAGX stock, for now, is neutral, meaning that the shares are stable in terms of price movement. The stochastic readings, on the other hand, based on the current JAGX readings is similarly very revealing as it has a stochastic reading of 18.4% at this stage. This figure means that JAGX share price today is being overbought.
Technical chart claims that Jaguar Health, Inc. (JAGX) would settle between $0.26/share to $0.27/share level. However, if the stock price goes below the $0.23 mark, then the market for Jaguar Health, Inc. becomes much weaker. If that happens, the stock price might even plunge as low as $0.22 for its downside target. The stock is currently in the red zone of MACD, with the indicator reading -0.03. Traders are always alerted for the move of a stock above or below the zero line due to the fact that the reading is an indicator of the position of the short-term average relative to the long-term average. If the MACD is above the zero line, then the short-term average relative is above that of the long-term average, thus implying an upward momentum. Vice versa is the case if the MACD is below the zero line.
Analysts at Rodman & Renshaw, assumed coverage of JAGX assigning Buy rating, according to their opinion released on July 11.
Moving on, JAGX stock price is currently trading at 0X forward 12-month Consensus EPS estimates, and its P/S ratio is 7.91 while for the average stock in the same group, the multiple is 49.5.